| Terpenoid ID | TKC116328 |   | 
| Cell line | 0 | |
| Protein target | 1 | |
| DiseaseNCIT | 0 | |
| ORDO | 0 | |
| ICD | 7 | 
 
  
  
| ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO | 
|---|---|---|---|---|---|---|---|
| TKC116328 | SH-SY5Y | SH-Sy5y; SHSY5Y; SHSY-5Y; SK-SH-SY5Y; SY5Y; SH-SY5Y Parental | 11.0 | % | Activity | C3270 | Orphanet_635 | 
| ID | Uniport | Pref_name | Gene name | value | unit | type | 
|---|---|---|---|---|---|---|
| TKC116328 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3800 | nM | IC50 | 
| TKC116328 | P17706 | Tyrosine-protein phosphatase non-receptor type 2 | PTPN2 | <50 | % | Inhibition | 
| TKC116328 | P10586 | Receptor-type tyrosine-protein phosphatase F | PTPRF | <50 | % | Inhibition | 
| TKC116328 | P29350 | Tyrosine-protein phosphatase non-receptor type 6 | PTPN6 | <50 | % | Inhibition | 
| TKC116328 | Q06124 | Tyrosine-protein phosphatase non-receptor type 11 | PTPN11 | <50 | % | Inhibition | 
| TKC116328 | P30305 | M-phase inducer phosphatase 2 | CDC25B | <50 | % | Inhibition | 
| Uniport ID | Uniport Name | ICD-11 | 
|---|---|---|
| P18031 | PTN1_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] | 
| P18031 | PTN1_HUMAN | Acute diabete complication [ICD-11: 5A2Y] | 
| P18031 | PTN1_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] | 
| P18031 | PTN1_HUMAN | Obesity [ICD-11: 5B80-5B81] | 
| P18031 | PTN1_HUMAN | Ophthalmic devices/implants/grafts injury [ICD-11: PK97] | 
| P18031 | PTN1_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] | 
| P18031 | PTN1_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] | 
| P18031 | PTN1_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] | 
| P17706 | PTN2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | 
| Q06124 | PTN11_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | 
| P30305 | MPIP2_HUMAN | Lung cancer [ICD-11: 2C25] | 
| P30305 | MPIP2_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] | 
| P30305 | MPIP2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |